If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBenchmark Holdings Regulatory News (BMK)

  • There is currently no data for BMK

Director Share Options

25 Jan 2018 11:54

RNS Number : 9419C
Benchmark Holdings PLC
25 January 2018
 

25 January 2018

 

BENCHMARK HOLDINGS PLC("Benchmark" or the "Company")

DIRECTOR SHARE OPTIONS

Benchmark Holdings plc announces that on 24 January 2018, and in accordance with the intention disclosed in its Annual Report and Accounts published on 23 January 2018, options over Ordinary Shares of 0.1 pence each ("Ordinary Shares") were granted to Malcolm Pye, Chief Executive Officer and Mark Plampin, Chief Financial Officer under the Company Share Option Plan (CSOP) in lieu of a cash bonus in respect of the 2017 financial year.

Options over a total of 500,000 Ordinary Shares were granted to Malcolm Pye and options over a total of 400,000 Ordinary Shares were granted to Mark Plampin. Following this grant, Malcolm Pye remains interested in 15,145,686 Ordinary Shares and holds options over a total of 500,000 Ordinary Shares in the Company, representing approximately 2.90% and 0.10% of Benchmark's existing issued share capital respectively. Mark Plampin remains interested in 536,686 Ordinary Shares and holds options over a total of 524,585 Ordinary Shares in the Company, representing approximately 0.10% and 0.10% of Benchmark's existing issued share capital respectively.

The options granted have a vesting period of three years, may be exercised up to the tenth anniversary of grant, have an exercise price of 69.5 pence per Ordinary Share, and are not subject to performance criteria.

 

Notification and public disclosure of a transactions by a persons discharging managerial responsibilities: 

 

Details of the person discharging managerial responsibilities / person closely associated 

 

a) 

 

Name 

 

Malcolm Pye

 

Reason for the notification 

 

a) 

 

Position/status 

 

Executive Director 

b) 

 

Initial notification/Amendment 

 

Initial

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

 

a) 

 

Name

 

Benchmark Holdings plc

b) 

 

LEI 

n/a

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a) 

 

Description of the financial instrument, type of instrument 

Identification code 

 

0.1p ordinary shares

ISIN: GB00BGHPT808 

b) 

 

Nature of the transaction 

 

Issue of share options under Company Share Option Plan (CSOP)

c) 

 

Price(s) and volume(s) 

 

 

Exercise price

 

Volume(s)

69.5 pence

500,000

d) 

 

Aggregated information

- Aggregated volume 

- Price 

 

Volume: 500,000

Price: Nil

e) 

 

Date of the transaction 

 

24 January 2018

f) 

 

Place of the transaction 

 

AIM Market, London Stock Exchange

 

 

 

 

Details of the person discharging managerial responsibilities / person closely associated 

 

a) 

 

Name 

 

Mark Plampin 

 

Reason for the notification 

 

a) 

 

Position/status 

 

Executive Director 

b) 

 

Initial notification/Amendment 

 

Initial

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

 

a) 

 

Name

 

Benchmark Holdings plc

b) 

 

LEI 

n/a

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a) 

 

Description of the financial instrument, type of instrument 

Identification code 

 

0.1p ordinary shares

ISIN: GB00BGHPT808 

b) 

 

Nature of the transaction 

 

Issue of share options under Company Share Option Plan (CSOP)

c) 

 

Price(s) and volume(s) 

 

 

Exercise price

 

Volume(s)

69.5 pence

400,000

d) 

 

Aggregated information

- Aggregated volume 

- Price 

 

Volume: 400,000

Price: Nil

e) 

 

Date of the transaction 

 

24 January 2018

f) 

 

Place of the transaction 

 

AIM Market, London Stock Exchange

 

 

 

ENDS

 

 

 

Benchmark Holdings plc

Tel: 020 7920 3150

Malcolm Pye, CEO

Ivonne Cantu, Investor Relations Director

Rachel Aninakwah, Communications

Numis

Tel: 020 7260 1000

Michael Meade / Freddie Barnfield (NOMAD)

James Black (Corporate Broking)

MHP

Katie Hunt / Reg Hoare / Alistair de Kare-Silver

Tel: 020 3128 8742 07551 170 451

benchmark@mhpc.com

 

Notes to Editors:

Benchmark challenges the status quo in aquaculture. Since 2000, Benchmark has consistently worked to build a technology-rich platform in the areas of genetics, nutrition, animal health and knowledge services, to serve its customers, helping them take control of their biological environment to improve yield and efficiency in a sustainable way. 

The Company has leading positions in its core markets and established R&D, manufacturing and distribution capabilities to serve all the major aquaculture markets. Benchmark operates in 27 countries in five continents and as at 30 September 2017, it employed 950 people. 

For further information on Benchmark please visit www.benchmarkplc.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHBAMBTMBATBJP
Date   Source Headline
19th Mar 20217:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
26th Feb 202110:52 amRNSTotal Voting Rights
22nd Feb 20217:00 amRNSQ1 Results
9th Feb 202112:43 pmRNSResult of AGM
9th Feb 20217:00 amRNSNotice of Q1 Results
29th Jan 20217:00 amRNSTotal Voting Rights
13th Jan 20217:00 amRNSIssue of Equity
8th Jan 20211:13 pmRNSReplacement: DIRECTOR SHARE OPTIONS
8th Jan 20219:57 amRNSDIRECTOR SHARE OPTIONS
6th Jan 20213:45 pmRNSDirector Dealings
31st Dec 20207:00 amRNSTotal Voting Rights
11th Dec 20205:32 pmRNSPosting of Annual Report and Notice of AGM
2nd Dec 20202:09 pmRNSDirector Dealings
1st Dec 20204:02 pmRNSAnnual Financial Report
1st Dec 202011:30 amRNSDirector Dealings
1st Dec 202010:30 amRNSDirector Dealings
1st Dec 202010:21 amRNSPCA Dealing
30th Nov 20207:00 amRNSTotal Voting Rights
27th Nov 20207:00 amRNSQ4 Results
27th Nov 20207:00 amRNSFull Year Results
18th Nov 20207:00 amRNSDirectorate Change
4th Nov 20207:00 amRNSInvestor Presentation for Retail Investors
30th Oct 20207:00 amRNSTotal Voting Rights
27th Oct 20207:00 amRNSNotice of Results
13th Oct 20202:29 pmRNSHolding(s) in Company
12th Oct 20202:50 pmRNSHolding(s) in Company
30th Sep 20207:00 amRNSTotal Voting Rights
29th Sep 20207:00 amRNSHolding(s) in Company
21st Sep 20207:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
11th Sep 20205:58 pmRNSHolding(s) in Company
10th Sep 20209:15 amRNSPositive Opinion from the EMA on BMK08
4th Sep 20207:00 amRNSDirector/PDMR Shareholding
28th Aug 20207:00 amRNSTotal Voting Rights
28th Aug 20207:00 amRNSQ3 Results
21st Aug 20207:00 amRNSNotice of Q3 Results
31st Jul 202011:17 amRNSCompletion of sale of vaccine facility
31st Jul 20207:00 amRNSTotal Voting Rights
23rd Jul 202011:05 amRNSSale of vaccine manufacturing assets
1st Jul 20207:00 amRNSSale of FishVet
30th Jun 20207:00 amRNSTotal Voting Rights
23rd Jun 20207:00 amRNSSale of Improve International
8th Jun 20204:54 pmRNSDirector/PDMR Shareholding - Replacement
8th Jun 202010:43 amRNSDirector/PDMR Shareholding
5th Jun 20205:50 pmRNSDirector/PDMR Shareholding
29th May 20207:00 amRNSTotal Voting Rights
29th May 20207:00 amRNSSecond Quarter and Interim Results
27th May 20208:30 amRNSEquity Development Results Webinar
19th May 20207:00 amRNSNotice of Q2 and Interim Results
6th May 202012:09 pmRNSHolding(s) in Company
30th Apr 20207:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.